- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 11.28M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $280.66M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $280.41M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $31.52M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $33.54M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $65.21M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $75.59M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $381.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $385.28M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $192.61M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $203.04M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $351.91M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $349.66M |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $25.5M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $26.04M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 11.77M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.25M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.51M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $8.87M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$48.45M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$51.94M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.46 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.48 |
| Net Income | Q1 2025 · Mar 31, 2024 | $5.46M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $14.15M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $41.52M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $70.42M |
| Revenue | Q1 2025 · Mar 31, 2024 | $111.94M |